Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2025-12-24 @ 3:21 PM
NCT ID:
NCT00732992
Eligibility Criteria:
Inclusion Criteria:
* Patients with a diagnosis of a solid malignancy that is refractory to standard therapy or for which no standard therapy exists.
* Patients has a good performance status (ECOG 0 or 1)
Exclusion Criteria:
* Prior treatment with either pemetrexed or SU011248.
* Coughing up blood within 4 weeks before starting study treatment (small amounts okey).
* Hypertension that cannot be controlled by medications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00732992
Study Brief:
Protocol Section:
NCT00732992